Oka, Satoko <br/><br/>
Clinical effects of the CD13/CD33 ratio on the prognosis of myelodysplastic syndrome treated with azacitidine.  [electronic resource] 

 -  Leukemia & lymphoma  05 2020 
 - 1250-1253 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2020.1711903  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azacitidine--therapeutic use<br/>CD13 Antigens<br/>Humans<br/>Myelodysplastic Syndromes--diagnosis<br/>Prognosis<br/>Sialic Acid Binding Ig-like Lectin 3